프로그램

제6회 삼성서울병원 암병원 심포지엄
  • 2022-11-19
  • Symposium(B1)
  • Nursing Session(B2)
CAR T-cell therapy : “The living drug for future cancer world”
시간 강의제목 발표자 소속
08:30~09:00 Registration
09:00~09:05 Opening
(Executive Vice President, SMC & General
Director, Cancer Center)
Woo Yong Lee, M.D. SMC, Korea
09:05~09:10 Welcome Address
(President & CEO Samsung Medical Center)
Seung Woo Park, M.D. SMC, Korea
Session I. CAR T-cell therapy in lymphoid malignancy Ki Woong Sung, M.D. SMC, Korea
09:10~09:40 Current status of CAR T-cell therapy in SMC Won Seog Kim, M.D. SMC, Korea
09:40~10:10 Approved and emerging CAR T-cell therapy
in lymphoma
Anna Sureda, M.D. Institut Català d'Oncologia-Hospitalet, Barcelona, Spain
10:10~10:40 CAR T-cell therapy in pediatric malignancy Hee Young Ju, M.D SMC, Korea
10:40~11:00 Coffee Break
Session II. CAR T-cell therapy in solid tumors Joon Oh Park, M.D SMC, Korea
11:00~11:30 CAR T-cell therapy in gastric cancer Changsong Qi, M.D. Peking University, China
11:30~12:00 CAR T-cell therapy for solid tumors based on a new concept Hiroshi Fujiwara, M.D. Mie University, Japan
12:00~13:00 Lunch
Session Ⅲ. CAR T-cell therapy for future clinical practice Yeup Yoon, Ph.D. SMC, Korea
13:00~13:30 Practical issues of CAR T-cell therapy Seok Jin Kim, M.D. SMC, Korea
13:30~14:00 Reimagining the Future of Cancer Care with CAR-T Bernd Eschgfaeller, Ph.D. Novartis, Switzerland
14:00~14:30 Gene editing and CAR T-cell therapy Dae Sik Kim, Ph.D. Sungkyunkwan University, Korea
14:30~14:50 Coffee Break
Session IV. Next generation CAR T-cell therapy Won Seog Kim, M.D. SMC, Korea
14:50~15:20 Engineering Next-Generation CAR T-cell therapy for cancer therapy Yvonne Chen, Ph.D. University of California, Los Angeles, USA
15:20~15:50 Next Generation CAR T-cell therapy against hematological malignancies Kyungho Choi, M.D. SNU, Korea
15:50~16:20 iPSC-derived CAR T-cell therapy Maria Themeli, M.D. Cancer Center Amsterdam, Netherlands
16:20~16:50 Towards Next-generation T-cell Engineering for Cancer Chan Hyuk Kim, Ph.D. KAIST, Korea
16:50~17:00 Closing
(Director, Division of Hematology-Oncology
CAR T-cell Therapy Center)
Won Seog Kim, M.D. SMC, Korea